Cited by 159Cardiac electrophysiology and arrhythmiasCardiac Arrhythmias and TreatmentsCardiovascular Effects of Exercise

Brugada syndrome and supraventricular tachyarrhythmias: a novel association?

Open access
ECKARDT, LARS, KIRCHHOF, PAULUS, LOH, PETER, SCHULZE‐BAHR, ERIC, JOHNA, ROBERT, WICHTER, THOMAS, BREITHARDT, GÜNTER, HAVERKAMP, WILHELM +1 more·2001·Journal of Cardiovascular Electrophysiology

Abstract

Brugada Syndrome and Supraventricular Tachyarrhythmias. Introduction: The Brugada syndrome is a distinct form of idiopathic ventricular fibrillation characterized by a unique ECG pattern consisting of a right bundle branch block‐like aspect and ST segment elevation in leads V 1 to V 3. As a high induction rate of ventricular tachyarrhythmias has been reported in Brugada syndrome, we hypothesized that this also may be true for supraventricular tachycardias in these patients. Methods and Results: Between January 1995 and December 2000, we identified 35 consecutive patients with Brugada syndrome; 26 had a history of cardiac arrest or syncope and 9 were asymptomatic. All patients underwent electrophysiologic study, including an atrial and ventricular stimulation protocol. Ten patients (29%) were found to have supraventricular tachyarrhythmias (SVT) in addition to the Brugada syndrome. These 10 patients presented with aborted sudden cardiac death (n = 3) and/or a family history of sudden cardiac death (n = 4), syncope (n = 4), or primarily with a Brugada typical ECG, a positive family history, and palpitations (n = 2). Eight of them underwent genetic testing, but only 1 had a mutation in the SCN5A gene. In 6 patients, an AV nodal reentrant tachycardia was easily and reproducibly inducible. Two patients had clinical documented and inducible episodes of an atrial tachycardia (1 in addition to an AV nodal reentrant tachycardia). One patient had paroxysmal atrial fibrillation alternating with sinus rhythm, and 2 patients with accessory pathways were identified. Conclusion: This is the first description of an association of the Brugada syndrome with SVT. Thus, the arrhythmogenic substrate in Brugada syndrome may not be restricted to the ventricular level. Palpitations in this syndrome should raise the possibility of SVT. Conversely, in patients with SVT and aborted sudden cardiac death or syncope not related to SVT, the Brugada syndrome should be considered a possible additional electrophysiologic abnormality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1540-8167.2001.00680.x

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Still being checked.

Research works printed but not linked: 17

  1. Brugada P, Brugada J: Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Car- diol 1992;20:1391-1396.
  2. Alings M, Wilde A: "Brugada" syndrome: Clinical data and suggested pathophysiological mechanism. Circulation 1999;99:666-673.
  3. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, Potenza D, Moya A, Borggrefe M, Breithardt G, Ortiz LR, Wang Z, Antzelevitch C, O' Brien RE, Schulze BE, Keating MT, Towbin JA, Wang Q: Genetic basis and molecular mechanism for idiopathic ven- tricular brillation. Nature 1998;392:293-296.
  4. Antzelevitch C: The Brugada syndrome: Ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 2001;12:268-272.
  5. Brugada J, Brugada P, Brugada R: The syndrome of right bundle branch block ST segment elevation in V1 to V3 and sudden death: The Brugada syndrome. Europace 1999;1:156-166.
  6. Eckardt L, Kirchhof P, Johna R, Haverkamp W, Breithardt G, Borg- grefe M: WPW syndrome associated with Brugada syndrome. PACE 2001; (In press).
  7. Kakishita M, Kurita T, Matsuo K, Taguchi A, Suyama K, Shimizu W, Aihara N, Kamakura S, Yamamoto F, Kobayashi J, Kosakai, Ohe T: Mode of onset of ventricular brillation in patients with Brugada syndrome detected by implantable cardioverter de brillator therapy. J Am Coll Cardiol 2000;36:1646-1653.
  8. Gussak I, Antzelevitch C, Bjerregaard P, Towbin JA, Chaitman BR: The Brugada syndrome: Clinical, electrophysiologic and genetic as- pects. J Am Coll Cardiol 1999;33:5-15.
  9. Kirchhof P, Eckardt L, Mo ¨nnig G, Johna R, Loh P, Schulze-Bahr E, Breithardt G, Borggrefe M, Haverkamp W: A patient with "atrial torsades de pointes." J Cardiovasc Electrophysiol 2000;11:806-811.
  10. Priori SG, Napolitano C, Gasparini M, Pappone C, Della BP, Brignole M, Giordano U, Giovannini T, Menozzi C, Bloise R, Crotti L, Terreni L, Schwartz PJ: Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families. Circulation 2000;102:2509-2515.
  11. Montoya PT, Brugada P, Smeets J, Talajic M, Della Bella P, Lezaun R, vd Dool A, Wellens HJ, Bayes de Luna A, Oter R, Breithardt G, Borggrefe M, Klein H, Kuck KH, Kunze K, Coumel P, Leclercq JF, Chouty F, Frank R, Fontaine G: Ventricular brillation in the Wolff- Parkinson-White syndrome. Eur Heart J 1991;12:144-150.
  12. Pietersen AH, Andersen ED, Sandoe E: Atrial brillation in the Wolff- Parkinson-White syndrome. Am J Cardiol 1992;70:38A-43A.
  13. Leitch JW, Klein GJ, Yee R, Leather RA, Kim YH: Syncope associ- ated with supraventricular tachycardia. An expression of tachycardia rate or vasomotor response? Circulation 1992;85:1064-1071.
  14. O ¨berg B, Thore ´n P: Increased activity in left ventricular receptors during hemorrhage or occlusion of caval veins in the cat: A possible cause of the vaso-vagal reaction. Acta Physiol Scand 1972;85:164-173.
  15. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S: Autonomic and antiarrhythmic drug modulation of ST segment eleva- tion in patients with Brugada syndrome. J Am Coll Cardiol 1996;27: 1061-1070.
  16. Brugada R, Brugada J, Antzelevitch C, Kirsch GE, Potenza D, Towbin JA, Brugada P: Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000;101:510-515.
  17. Eckardt et al. Brugada Syndrome and Supraventricular Tachyarrhythmias 685 15408167, 2001, 6, Downloaded from https://onlinelibrary.wiley.com/doi/10.1046/j.1540-8167.2001.00680.x by Mount Vernon Nazarene University, Wiley Online Library on [23/06/2026]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License · DOI

Cited by

Sorted by citations

Authors
ECKARDT, L., KIRCHHOF, P., LOH, P., SCHULZE‐BAHR, E., JOHNA, R., WICHTER, T., BREITHARDT, G., HAVERKAMP, W., & BORGGREFE, M.
Affiliations
  • University of Münster (DE)
  • Heidelberg University (DE)
Corresponding author
  • ECKARDT, LARS
  • HAVERKAMP, WILHELM
Venue
Journal of Cardiovascular Electrophysiology
Publisher
Wiley
Published
2001-06
Volume
12
Issue
6
Pages
680-685
ISSN
  • 1045-3873 (ISSN-L)
  • 1540-8167
OpenAlex
W1986672101
Cited by
159
References
0
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 6 · 2019: 1 · 2018: 6 · 2017: 5 · 2016: 8 · 2015: 8 · 2014: 4 · 2013: 6 · 2012: 6
FWCI
6.09
Type
journal article
Language
en
Open access
Locations
  • Journal of Cardiovascular Electrophysiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Deutsche Forschungsgemeinschaft
  • Bundesministerium für Bildung und Forschung
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Keywords
Brugada syndrome, supraventricular tachyarrhythmias, atrioventricular nodal reentrant tachycardia, atrial tachycardia, paroxysmal atrial fibrillation, accessory pathway, sudden cardiac death, syncope, electrophysiological study, arrhythmogenic substrate, SCN5A mutation
MeSH terms
Adult, Bundle-Branch Block, Cardiac Pacing, Artificial, Electrocardiography, Female, Heart Arrest, Humans, Male, Middle Aged, Retrospective Studies, Tachycardia, Supraventricular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review